drugset / Trial / NCT07143318
First-in-Human Single and Multiple Dose of KLA578-1 for Injection
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers
Timeline
- Start
- 2025-06-05
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etopcoxib | Unknown | 120 mg | Oral |
| Subject | KLA578-1 | Unknown | 60 mg | Intravenous |
| Subject | KLA578-1 | Unknown | 120 mg | Intravenous |
| Subject | KLA578-1 | Unknown | 240 mg | Intravenous |
Indications
No indication recorded.